| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,371,000 | 3,610,000 | 1,884,000 | 1,024,000 | | Cost of Revenue | 1,211,000 | 1,778,000 | 1,782,000 | (591,000) | | | Gross Profit | 1,160,000 | 1,832,000 | 102,000 | 1,615,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 537,000 | 452,000 | 156,000 | 1,036,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 206,000 | 514,000 | (134,000) | 186,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 417,000 | 866,000 | 80,000 | 393,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 19,000 | (1,000) | 7,000 | 8,000 | | Earnings Before Interest And Taxes | 436,000 | 865,000 | 87,000 | 401,000 | | Interest Expense | 89,000 | 223,000 | 18,000 | 110,000 | | Income Before Tax | 347,000 | 642,000 | 69,000 | 291,000 | | Income Tax Expense | 101,000 | 218,000 | (4,000) | 97,000 | | Minority Interest |
-
| (19,000) | 9,000 | (5,000) | | | | Net Income From Continuing Ops | 246,000 | 405,000 | 82,000 | 189,000 | | | Non-recurring Events | | Discontinued Operations |
-
| 3,000 | (10,000) | 1,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 246,000 | 408,000 | 72,000 | 190,000 | | Preferred Stock And Other Adjustments | (5,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $241,000 | $408,000 | $72,000 | $190,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
